View key dates, Frequently Asked Questions, and additional resources to help you make the most of the NeuroStar Co-op program.
Important milestones, and key Co-op Program dates to ensure your Co-op participation stays on track:
Q2 – Purchase by June 30th
Purchase Treatment Sessions on Webstore
Q2 Co-op Marketing Reimbursement:
Co-op Marketing is designed to help you build patient awareness of NeuroStar and improve patients’ access to care. The Keys to Co-op are designed to identify the most impactful programs and marketing tactics with proven assets, and preferred vendors so you can get the most out of your marketing. Your PDM can help you with detailed guidance for how Co-op will most specifically benefit your practice.
You can submit your ads at any time, best practice is to submit ads a minimum of two weeks prior to the date you plan to run your ads. Keep in mind that your ads will be subject to the maximum reimbursement amount based on the Co-op Level you are in during the quarter the ads are run. The NeuroStar Co-op team takes 3-5 business days to review ad submissions so submit your ads with enough time ahead of your scheduled ad run date.
Reimbursement payment will be sent the following quarter. For example, if you submit your ads in Q2 (April 1st – June 30th), you will receive your reimbursement check by the end of Q3 (July 1st – September 30th) after co-op marketing receives the necessary documents to process the reimbursement requests by the specified deadline. NeuroStar offers two forms of payment, either by check or a quicker reimbursement via ACH.
No other advertising is reimbursable through Co-op at this time.
For additional information, please reach out to your Practice Development Manager (PDM) for assistance.
Leverage the power of NeuroStar branding on your website. Discover key elements to include on your NeuroStar page to effectively promote this service in your practice.
Copyright @ 2024 Neuronetics. All Rights Reserved.
Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
NeuroStar Advanced Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar Advanced Therapy has not been studied in patients who have not received prior antidepressant treatment.
Copyright @ 2021 Neuronetics. All Rights Reserved.
Visit https://neurostar.com for indications for use and safety information
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |